Evidence map›Paper›PMID 19737351›Full record

ArticleMolecular microbiology2009

The right half of the Escherichia coli replication origin is not essential for viability, but facilitates multi-forked replication.

Nicholas Stepankiw, Akihiro Kaidow, Erik Boye, David Bates

Open access · bronzeAbstract read
In one paragraph

Article in Molecular microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. IHF and Fis asInternational journal of molecular sciences · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Structure and Function of theFrontiers in microbiology · 2018
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Nicholas StepankiwDepartment of Human and Molecular Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Akihiro Kaidow
Erik Boye
David Bates
Baylor College of Medicine · USNorwegian Cancer Society · NOUniversity of New Mexico · US

Funding

THE ROLE OF SEQA PROTEIN IN E.COLI REPLICATION CONTROLF32GM020627 · NIGMS · HARVARD UNIVERSITY · PI BATES, DAVID · 2000 to 2001
$73k
NIGMS NIH HHS F32 GM020627
6 · The paper itself

Abstract

Replication initiation is a key event in the cell cycle of all organisms and oriC, the replication origin in Escherichia coli, serves as the prototypical model for this process. The minimal sequence required for oriC function was originally determined entirely from plasmid studies using cloned origin fragments, which have previously been shown to differ dramatically in sequence requirement from the chromosome. Using an in vivo recombineering strategy to exchange wt oriCs for mutated ones regardless of whether they are functional origins or not, we have determined the minimal origin sequence that will support chromosome replication. Nearly the entire right half of oriC could be deleted without loss of origin function, demanding a reassessment of existing models for initiation. Cells carrying the new DnaA box-depleted 163 bp minimal oriC exhibited little or no loss of fitness under slow-growth conditions, but were sensitive to rich medium, suggesting that the dense packing of initiator binding sites that is a hallmark of prokaryotic origins, has likely evolved to support the increased demands of multi-forked replication.

Indexed as

DNA ReplicationReplication OriginDNA, BacterialEscherichia coliMutagenesisOrigin Recognition ComplexSequence DeletionDNA, BacterialOriC chromosomal replication originOrigin Recognition Complex

Identifiers

PMID19737351
PMCPMC2967437
OpenAlexW2121762926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.